Literature DB >> 21916490

Mass spectrometric characterization of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine N-oxidized metabolites bound at Cys34 of human serum albumin.

Lijuan Peng1, Robert J Turesky.   

Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (n class="Chemical">PhIP) is a heterocyclic aromatic amine that is formed during the cooking of meats and poultry. PhIP is a carcinogen in rodents and a potential human carcinogen. Several short-term biomarkers of PhIP have been established for human biomonitoring, but validated long-term biomarkers of the biologically effective dose of PhIP remain to be developed. Metabolites of PhIP have been reported to covalently bind to human serum albumin (SA), which is the most abundant protein in plasma; however, the chemical structures of PhIP-SA adducts are unknown. Cysteine(34) is one of 35 conserved Cys residues in SA across species. Thirty-four of these Cys are involved in 17 disulfide bonds. The single unpaired Cys(34) residue in SA is well-known to react with carcinogenic metabolites and toxic electrophiles. 2-Nitro-1-methyl-6-phenylimidazo[4,5-b]pyridine (NO(2)-PhIP), 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (HONH-PhIP), and 2-nitroso-1-methyl-6-phenylimidazo[4,5-b]pyridine (NO-PhIP), three genotoxic metabolites of PhIP, were reacted with purified human SA or human plasma, and the SA adduction products, following enzymatic digestion, were separated by ultra performance liquid chromatography and characterized with a linear quadrupole ion trap mass spectrometer. The major adduct of NO(2)-PhIP was formed at the Cys(34) of SA with bond formation occurring between the sulfhydryl group of Cys and the C-2 imidazole atom of PhIP. The major adducts formed between SA and HNOH-PhIP or NO-PhIP were identified as acid-labile sulfinamide linkages at Cys(34). These PhIP-SA adducts represent a measure of bioactivation of PhIP and may serve as long-term biomarkers of the biologically effective dose of PhIP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21916490      PMCID: PMC3221794          DOI: 10.1021/tx2003504

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  57 in total

Review 1.  Protein adducts in the molecular dosimetry of chemical carcinogens.

Authors:  P L Skipper; S R Tannenbaum
Journal:  Carcinogenesis       Date:  1990-04       Impact factor: 4.944

2.  Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.

Authors:  H G Neumann
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

Review 3.  Structure of serum albumin.

Authors:  D C Carter; J X Ho
Journal:  Adv Protein Chem       Date:  1994

4.  Biological markers of exposure to benzene: S-phenylcysteine in albumin.

Authors:  W E Bechtold; J K Willis; J D Sun; W C Griffith; T V Reddy
Journal:  Carcinogenesis       Date:  1992-07       Impact factor: 4.944

5.  The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry.

Authors:  A M Lynch; S Murray; A R Boobis; D S Davies; N J Gooderham
Journal:  Carcinogenesis       Date:  1991-06       Impact factor: 4.944

6.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

Authors:  R J Turesky; N P Lang; M A Butler; C H Teitel; F F Kadlubar
Journal:  Carcinogenesis       Date:  1991-10       Impact factor: 4.944

7.  Binding of 2-amino-3-methylimidazo[4,5-f]quinoline to hemoglobin and albumin in vivo in the rat. Identification of an adduct suitable for dosimetry.

Authors:  R J Turesky; P L Skipper; S R Tannenbaum
Journal:  Carcinogenesis       Date:  1987-10       Impact factor: 4.944

8.  Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin.

Authors:  A M Lynch; S Murray; K Zhao; N J Gooderham; A R Boobis; D S Davies
Journal:  Carcinogenesis       Date:  1993-02       Impact factor: 4.944

9.  Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.

Authors:  M S Bryant; P Vineis; P L Skipper; S R Tannenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Formation of a glutathione conjugate and a semistable transportable glucuronide conjugate of N2-oxidized species of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat liver.

Authors:  J Alexander; H Wallin; O J Rossland; K E Solberg; J A Holme; G Becher; R Andersson; S Grivas
Journal:  Carcinogenesis       Date:  1991-12       Impact factor: 4.944

View more
  13 in total

1.  Mass Spectrometric Characterization of Human Serum Albumin Adducts Formed with N-Oxidized Metabolites of 2-Amino-1-methylphenylimidazo[4,5-b]pyridine in Human Plasma and Hepatocytes.

Authors:  Yi Wang; Lijuan Peng; Medjda Bellamri; Sophie Langouët; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2015-04-10       Impact factor: 3.739

2.  Mapping serum albumin adducts of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by data-dependent tandem mass spectrometry.

Authors:  Lijuan Peng; Surendra Dasari; David L Tabb; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2012-08-14       Impact factor: 3.739

3.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-07-10       Impact factor: 3.739

4.  Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans.

Authors:  Yi Wang; Peter W Villalta; Lijuan Peng; Karen Dingley; Michael A Malfatti; K W Turteltaub; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2017-01-18       Impact factor: 3.739

Review 5.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

6.  A miRNA signature for an environmental heterocyclic amine defined by a multi-organ carcinogenicity bioassay in the rat.

Authors:  Ying-Shiuan Chen; Rong Wang; Wan-Mohaiza Dashwood; Christiane V Löhr; David E Williams; Emily Ho; Susanne Mertens-Talcott; Roderick H Dashwood
Journal:  Arch Toxicol       Date:  2017-03-13       Impact factor: 5.153

7.  2-Amino-9H-pyrido[2,3-b]indole (AαC) Adducts and Thiol Oxidation of Serum Albumin as Potential Biomarkers of Tobacco Smoke.

Authors:  Khyatiben V Pathak; Medjda Bellamri; Yi Wang; Sophie Langouët; Robert J Turesky
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

8.  Capturing labile sulfenamide and sulfinamide serum albumin adducts of carcinogenic arylamines by chemical oxidation.

Authors:  Lijuan Peng; Robert J Turesky
Journal:  Anal Chem       Date:  2012-12-28       Impact factor: 6.986

9.  Novel Transgenic Mouse Model for Studying Human Serum Albumin as a Biomarker of Carcinogenic Exposure.

Authors:  Jonathan Sheng; Yi Wang; Robert J Turesky; Kerri Kluetzman; Qing-Yu Zhang; Xinxin Ding
Journal:  Chem Res Toxicol       Date:  2016-04-14       Impact factor: 3.739

10.  Biomonitoring an albumin adduct of the cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in humans.

Authors:  Medjda Bellamri; Yi Wang; Kim Yonemori; Kami K White; Lynne R Wilkens; Loïc Le Marchand; Robert J Turesky
Journal:  Carcinogenesis       Date:  2018-12-31       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.